Supporting people to get tested and be free of hep C

The Hepatitis C Drug Service Provider Forum – Progress to Elimination
(44 minutes, 08 seconds)

Find out what the Gilead HCV Drug Treatment Services Provider Forum has developed to support HCV elimination in drug and alcohol services, what the priorities are for 2024 and how your organisation can get involved.

Speakers:
Matt Milner, Gilead Science
Marlon Freeman, Hepatitis C Coordinator

Updates from INHSU 2024
(42 minutes, 59 seconds)

The annual conference of the International Network on Health and Hepatitis in Substance Users is the primary conference for HCV elimination for the people and communities supported by drug and alcohol services and prison healthcare. Hear about the key themes of this year’s conference and learn more about the best practices presented from health care practitioners and peers with lived experience from around the world.

Speakers:
Irfan Chhipa, Gilead Sciences
Louise Hansford, Board Member, International Network on Health and Hepatitis in Substance Users
Marlon Freeman, National HCV Coordinator, VIA

Hepatitis C Micro elimination in drug and alcohol services – a practical framework
(44 minutes, 03 seconds)

Dive into how innovative partnerships and policy shifts are enabling micro-elimination of Hepatitis C in drug and alcohol services across the UK. Learn how NHS England’s commitment to simplification and collaboration with Operational Delivery Networks (ODNs) and drug treatment services (DTSs) is transforming patient outcomes and driving progress toward elimination goals.

Speakers:
Emma Lamond, National Improvements Manager, 'We Are With You'
Helen Hampton, Viral Hepatitis Nurse Specialist, Royal Cornwall Hospital & National Blood-Borne Virus Lead, 'We Are With You'
Irfan Chhipa, Gilead Sciences

Drug and Alcohol Service Standards for Hepatitis C Virus and other blood borne viruses (BBVs)
(33 minutes, 44 seconds)

The March Be Free of Hep C Series webinar focused on the Drug and Alcohol Service Standards for Hepatitis C and other Blood Borne Viruses, highlighting the collaborative approach to achieving micro-elimination. Speakers Laura Hughes and Hayley Curran explored the eight key standards, sharing practical insights on leadership, screening, data management, harm reduction, and partnership working, reinforcing the importance of sustained funding and commitment to eliminating Hepatitis C.

Speakers:
Matt Milner, Gilead Science
Hayley Curran, Mersey Care NHS Foundation Trust
Laura Hughes, Hep C U Later

Elimination 2024+ - What’s next for England?
(46 minutes)

Meet the clinical and programme leads for NHS England’s HCV Elimination Programme and learn what NHSE is prioritising for 2024 to help England eliminate HCV by 2025.

Speakers:
William McCully, Gilead Sciences
Professor Ashley Brown, Clinical Lead, NHSE HCV Elimination Programme
Mark Gillyon-Powell, Deputy Director - HCV Elimination & Health Inequalities, NHS England, Specialised Commissioning

Commissioning for Elimination: Sustainable HCV Pathways
(42 minutes, 28 seconds)

Find out how drug and alcohol commissioners in two different local authorities work closely with their services to commission and review BBV activities to help deliver HCV elimination locally, in line with the Provider Forum developed micro-elimination criteria and BBV standards.

Speakers:
Adrian Coleman, Gilead Sciences
Claire Brighton, Drug and Alcohol Programme Manager, Ealing Council
Lee Harrington, Public Health Specialist - Substance Use, Health Improvement, Public Health & Wellbeing, Lancanshire County Council

Assessment for HCV treatment: DTS led models and other blood borne viruses (BBV)
(39 minutes, 53 seconds)

Learn about the shift in policy by NHS England to simplify approaches taken to engage those who are reluctant to consider HCV treatment, and why collaborations between ODNs and DTSs are contributing to support this new policy.

Speakers:
Mark Gillyon-Powell, Head of Programme HCV Elimination, NHSE
Tracy Kemp, National Hepatitis C Strategy Lead, Change Grow Live
Christine Taylor, Gilead Sciences Ltd

Drug treatment services Hep C pathway workshop feedback
(14 minutes, 50 seconds)

Attendees at the Hep C Elimination workshop event present the outcomes of their collaborative discussions around real-life barriers and opportunities along the service user and provider pathway in the management of hep C.

Speakers:
Dr Prun Bujral, Medical Director, Change Grow Live (Hep C Elimination meeting co-chair)
Timothy Lilley, Patient Access to Care team, Gilead Sciences Ltd
Dean Linzey, BBV Consultant
Danny Morris, Midlands & West Regional Manager – Community Services, The Hepatitis C Trust
Dr Rebecca John, National Hepatitis C Lead, Turning Point
Debbie Moores, National Hepatitis C Coordinator, Humankind

Hepatitis C Micro Elimination in drug and alcohol services – a practical framework
(44 minutes, 03 seconds)

Dive into how innovative partnerships and policy shifts are enabling micro-elimination of Hepatitis C in drug and alcohol services across the UK. Learn how NHS England’s commitment to simplification and collaboration with Operational Delivery Networks (ODNs) and drug treatment services (DTSs) is transforming patient outcomes and driving progress toward elimination goals.

Speakers:
Emma Lamond, National Improvements Manager, 'We Are With You'
Helen Hampton, Viral Hepatitis Nurse Specialist, Royal Cornwall Hospital & National Blood-Borne Virus Lead, 'We Are With You'
Irfan Chhipa, Gilead Sciences

Drug and Alcohol Service Standards for Hepatitis C Virus and other blood borne viruses (BBVs)
(33 minutes, 44 seconds)

The March Be Free of Hep C Series webinar focused on the Drug and Alcohol Service Standards for Hepatitis C and other Blood Borne Viruses, highlighting the collaborative approach to achieving micro-elimination. Speakers Laura Hughes and Hayley Curran explored the eight key standards, sharing practical insights on leadership, screening, data management, harm reduction, and partnership working, reinforcing the importance of sustained funding and commitment to eliminating Hepatitis C.

Speakers:
Matt Milner, Gilead Science
Hayley Curran, Mersey Care NHS Foundation Trust
Laura Hughes, Hep C U Later

Every test counts
(41 minutes, 05 seconds)

In this special edition webinar, learn more about European Testing Week and hear real life stories from people who have had their lives transformed by being tested and treated for hepatitis C. Learn what you can do to help people using your services be free of hep C.

Speakers:
Wendy Tivey, Gilead Sciences
James Rock, Pan London Peer Programme Manager, UCLH Find & Treat BBV Coordinator & Specialist Outreach, The Hepatitis C Trust
Michael Roberts, Hepatitis C Trust Peer, The Hepatitis C Trust

At the heart of everything we do: A patient’s story
(7 minutes, 32 seconds)

Louise, cured from hep C, talks about her journey from diagnosis to treatment and being part of initiatives that achieved micro elimination.

Speakers:
Louise Hansford, NHS Addiction Provider Alliance (APA) / MPFT

Hepatitis C Micro Elimination: Reinfection and harm reduction
(38 minutes, 46 seconds)

In this meeting, Mark Roberts and Louise Wilkins discuss the topic of reinfections and harm reduction.

Speakers:
Sanjita Panchal, Gilead Sciences Ltd
Mark Roberts, North East & Cumbria, Peer Support Lead
Louise Wilkins, Nottinghamshire Healthcare Foundation Trust

The Hepatitis C Drug Service Provider Forum – Progress to Elimination
(44 minutes, 08 seconds)

Find out what the Gilead HCV Drug Treatment Services Provider Forum has developed to support HCV elimination in drug and alcohol services, what the priorities are for 2024 and how your organisation can get involved.

Speakers:
Matt Milner, Gilead Science
Marlon Freeman, Hepatitis C Coordinator

Sustaining Microelimination
(41 minutes, 01 seconds)

Learn how two different drug and alcohol services have sustained HCV micro-elimination for more than a year. Find out how they work in partnership with their local hepatology clinicians to support people using their services to Be Free of Hep C.

Speakers:
Christine Taylor, Gilead Sciences
Jael Mulholland, Hepatology Clinical Nurse Specialist, Chelsea and Westminster Hospital NHS Foundation Trust
Darja Golob, Addictions Performance Analyst, Central & North West London NHS Foundation Trust
Daniel Page, Deputy Service Manager, Waltham Forest, CGL
Jane Dalton, Community Viral Hepatitis Nurse Specialist, Royal London Hospital NHS Foundation Trust

Overcoming Refusals: Testing and Treatment Strategies
(32 minutes, 34 seconds)

Chaired by Tim Lilley, this webinar focuses on overcoming refusals and implementing effective Hepatitis C testing and treatment strategies. Featuring experts from CGL, including Jonathan Occleshaw, Alison Starkie, and Rachel Hudson, the session explores practical approaches to engaging clients in testing, ensuring successful treatment, and achieving micro-elimination across services in Lancashire and Hull.

Speakers:
Tim Lilley, Gilead Sciences
Johnathan Occleshaw, Hep C Regional Coordinator, Northwest, CGL
Alison Starkie, Hep C Intervention Worker, CGL
Rachel Hudson, Cluster Lead Nurse and Hepatitis C Treatment
Coordinator, Hull, Renew, CGL

Needs assessment programme
(33 minutes, 19 seconds)

Beatrice and Robert discuss how a pilot project at the Barts ODN helped develop and refine the Needs Assessment Programme, and why this programme is vital in reaching the NHS England elimination goal.

Click here to learn more about the Needs Assessment Project and how this is managed in Addiction Service and Needle exchanges/community pharmacy.

Speakers:
Beatrice Emmanouil, Analytics Lead, HCV Elimination NHS England
Robert Hammond, ODN Manager, Barts ODN
Christine Taylor, Gilead Sciences Ltd

Change Grow Live (CGL) Reading
(3 minutes, 43 seconds)

A motivational video from a Drug Treatment Services site, which achieved micro elimination of hep C; Safina Shahin, a Senior Healthcare Assistant, talks about how this was accomplished, and shares some of her best practice tips.

Change Grow Live (CGL) West Kent
(4 minutes, 35 seconds)

An inspirational video from a Drug Treatment Services site, which achieved micro elimination of hep C. Three members of the team responsible for this achievement; Jo Brown (Cluster Lead Nurse), Tracy Tinley (Substance Misuse RGN) and Linda Foreman (Viral Hepatitis CNS) talk about how they accomplished this.

Testing Events: Targeted strategies to support Micro Elimination
(41 minutes, 44 seconds)

Hepatitis C Trust representatives share how they are collaborating with DTSs to increase testing, and how these tactics supported Havering in becoming the first service to achieve hep C elimination in 2023.

Speakers:
Alan Howard, Peer-to-Peer Coordinator, Hepatitis C Trust Hampshire
Sean Caddy, Wessex Clinical Van Coordinator, Inclusion Recovery – Hampshire and Dorset
Isaac Onita, Blood Borne Virus (BBV) Lead, Aspire – Havering
Simon Pooley, Peer Project Manager, Hepatitis C Trust – North East London
Wendy Tivey, Gilead Sciences Ltd

Overcoming the challenges of achieving Micro Elimination in a large integrated service
(31 minutes)

Deborah Moores and Stacey Smith discuss the challenges of achieving micro-elimination in a large integrated service and how they overcome them.

Speakers:
Deborah Moores, National Hepatitis C Coordinator, Humankind
Stacey Smith, Director of Nursing, Humankind

Drug treatment services panel discussion – Ask the expert
(20 minutes, 29 seconds)

A multi-disciplinary panel explore and discuss topics around hep C treatment services, including engagement of local politicians, sharing of data between services, the impact of COVID-19 on service users and optimisation of access to services in the future. Facilitated by Rachel Halford, CEO, The Hepatitis C Trust

Speakers:
Rachel Halford, CEO, The Hepatitis C Trust
Dean Linzey, BBV Consultant
Professor John Dillon, Professor of Hepatology and Gastroenterology, Ninewells Hospital, University of Dundee
Mark Gillyon-Powell, Head of Programme for Hep C Elimination in England, NHSE
Denise Burridge, Director of Nursing, Change Grow Live
Louise Hansford, Hep C Coordinator South, NHS APA (Inclusion) / MPFT
Stuart Smith, Director of Community Services, The Hepatitis C Trust

Hepatitis C Micro Elimination: Evolving collaboration between Hepatitis C Trust peers and the ODN treatment team
(50 minutes, 11 seconds)

In this webinar, Duncan Cresswell and Samantha Readhead discuss the evolving collaboration between ODN team members and Hepatitis C Trust peers.

Speakers:
Duncan Cresswell (ODN Manager, Sussex ODN)
Samantha Readhead (ODN Lead Nurse, Sussex ODN)

Assessment for HCV treatment: DTS led models and other blood borne viruses (BBV)
(39 minutes, 53 seconds)

Learn about the shift in policy by NHSE to simplify approaches taken to engage those who are reluctant to consider HCV treatment, and why collaborations between ODNs and DTSs are contributing to support this new policy.

Speakers:
Mark Gillyon-Powell, Head of Programme HCV Elimination, NHSE
Tracy Kemp, National Hepatitis C Strategy Lead, Change Grow Live
Christine Taylor, Gilead Sciences Ltd

Drug treatment services panel discussion – Ask the expert
(20 minutes, 29 seconds)

A multi-disciplinary panel explore and discuss topics around hep C treatment services, including engagement of local politicians, sharing of data between services, the impact of COVID-19 on service users and optimisation of access to services in the future. Facilitated by Rachel Halford, CEO, The Hepatitis C Trust.

Speakers:
Rachel Halford, CEO, The Hepatitis C Trust
Dean Linzey, BBV Consultant
Professor John Dillon, Professor of Hepatology and Gastroenterology, Ninewells Hospital, University of Dundee
Mark Gillyon-Powell, Head of Programme for Hep C Elimination in England, NHSE
Denise Burridge, Director of Nursing, Change Grow Live
Louise Hansford, Hep C Coordinator South, NHS APA (Inclusion) / MPFT
Stuart Smith, Director of Community Services, The Hepatitis C Trust

Assessing and Treating HCV: A Clinical Guide for DTS-Led Delivery
(51 minutes, 36 seconds)

The ninth Be Free of Hep C webinar focused on Assessing and Treating HCV: A Clinical Guide for DTS-Led Delivery, highlighting the evolution of treatment pathways in West Kent CGL. Speakers Jo Brown and Laura Gallagher discussed the shift from hospital-led care to in-service treatment, emphasising the importance of stakeholder collaboration, streamlined pathways, and empowering drug treatment services to deliver hepatitis C treatment directly, ensuring more accessible and patient-centred care.

Speakers:
Speakers: Pinda Garcha, Gilead Sciences
Jo Brown, Change Grow Live
Laura Gallagher, South Thames ODN

Community Pharmacy Based Testing for HCV
(39 minutes, 07 seconds)

Community pharmacy can offer many opportunities to provide outreach services and support for people who may also access drug and alcohol services, including testing for hepatitis C. Learn about best practices being used by the Wessex Operational Delivery Network and the Hepatitis C Trust.

Speakers:
Pinda Garcha, Gilead Sciences
Dr Charlotte Cook, University of Southampton
Leila Reid, Director of Research and Corporate Services, The Hepatitis C Trust

HCV Testing and Needle & Syringe Provision
(40 minutes, 24 seconds)

As more drug and alcohol services reach HCV micro-elimination in structured care, needle and syringe provision services can offer new opportunities to engage people in testing and treatment for Hepatitis C. Hear about policy changes and pilot programmes that seek to increase testing in these settings.

Speakers:
Jenny Scott, PhD, Cert. IP, FRPharmS, FHEA. Senior Lecturer (Pharmacist) – Centre for Academic Primary Care (CAPC), Population Health Sciences, Bristol Medical School
Stuart Smith, Director of Community Services, The Hepatitis C Trust